Click to search for your profile
Click to search for condition or expert
Click to open main menu
Psoriasis Clinical Trials
Find Psoriasis Clinical Trials Near You
Save
Bookmark
Share
Share
Overview
Find a Doctor
Latest Advances
Clinical Trials
Clinical Trials
Search for trials
Filter
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
160
Start Date:
May 2, 2022
A Phase II, Randomised, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging, Proof-of-concept Trial of BI 730357 Given for 12 Weeks in Patients With Active Psoriatic Arthritis
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Other, Biological
Participants:
200
Start Date:
January 2022
Safety and Clinical Efficacy Associated With Faecal Microbiota Transplantation Performed in Treatment-naïve Patients With Newly Diagnosed Rheumatoid Arthritis, Reactive Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, Gouty Arthritis, Psoriasis, Hidradenitis Suppurativa, Pulmonary Sarcoidosis, Crohn's Disease, and Ulcerative Colitis: a 52-week, Double-blind, Randomised, Placebo-controlled, Exploratory Trial
Search for trials
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 3
Intervention Type:
Drug, Other
Participants:
40
Start Date:
September 24, 2021
A Phase III Randomized, Double-blind, Placebo Controlled, Multicenter, Bridging Study of Subcutaneous Secukinumab, to Demonstrate Efficacy After Sixteen Weeks of Treatment and to Assess Safety, Tolerability and Long-term Efficacy Follow-up to One Year in Chinese Subjects With Active Psoriatic Arthritis
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 4
Intervention Type:
Drug
Participants:
20
Start Date:
September 1, 2021
An Investigator Initiated Study Evaluating the Efficacy and Tolerability of Enstilar Foam (Calcipotriene and Betamethasone Dipropionate) in Patients With Nail Psoriasis
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 3
Intervention Type:
Drug
Participants:
450
Start Date:
September 1, 2021
A Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Who Had an Inadequate Response and/or Intolerance to One Prior Anti-Tumor Necrosis Factor Alpha Agent
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
80
Start Date:
September 2021
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of KBL697 in Patients With Moderate Plaque Type Psoriasis
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 4
Intervention Type:
Procedure, Drug
Participants:
20
Start Date:
September 2021
Immune Modification of Psoriasis by Selective IL-23 Blockade Using Risankizumab
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1/Phase 2
Intervention Type:
Biological
Participants:
5
Start Date:
August 31, 2021
Efficacy and Safety of Expanded Umbilical Cord Mesenchymal Stem Cells On Patients With Moderate to Severe Psoriasis
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 4
Intervention Type:
Drug
Participants:
405
Start Date:
August 20, 2021
A Phase 4, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 3
Intervention Type:
Drug
Participants:
70
Start Date:
August 2, 2021
A Randomized, Parallel-group, Double-blind, Placebo-controlled, Multicenter, 16-Week, Phase 3 Study to Investigate the Efficacy and Safety of Secukinumab (AIN457) 300 mg s.c. in Adult Patients With Active, Moderate to Severe Thyroid Eye Disease
Clinical Trial
Status:
Not yet recruiting
Participants:
1000
Start Date:
August 1, 2021
The Psoriasis Echo Study
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
76
Start Date:
August 1, 2021
Impact of Acute Cannabis Administration on Pain Symptomology and Inflammatory Markers Among Patients With Rheumatoid or Psoriatic Arthritis
Showing 1-12 of 418
Next